Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Two Lactobacilli Strains as Adjuvant Therapy in the Management of Irritable Bowel Syndrome: A Randomized Clinical Trial

NCT05523427 is registered in ClinicalTrials.gov with University of Mosul as lead sponsor.

NCT NCT05523427
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05523427 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Two Lactobacilli Strains as Adjuvant Therapy in the Management of Irritable Bowel Syndrome: A Randomized Clinical Trial
Lead sponsor
University of Mosul
Phase
Not applicable
Overall status
Completed
Start date
July 19, 2022
Completion date
January 6, 2023
Enrollment
100 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

irritable bowel syndrome, irritable bowel syndrome with diarrhea